Published by Josh White on 14th May 2021
(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commission (SEC), it announced on Friday, for a proposed dual-listing and public offering of shares on the Nasdaq market.
URL: http://www.digitallook.com/dl/news/story/31848087/...